How Often Should Kidney Cancer Be Monitored After Treatment?

After treatment for kidney cancer—whether surgery, ablation, or systemic therapy—ongoing follow-up is essential. Monitoring helps detect if the cancer has come back (recurrence) or if there are any long-term side effects from treatment. The schedule depends on the stage of the cancer, the type of treatment received, and your overall health.

General Follow-Up Guidelines

Doctors typically follow patients with:

Stage 1 or 2 cancer (early stage, localized)

• Imaging (CT, MRI, or ultrasound) every 6–12 months for the first 3 years
• Then annually up to year 5
• Periodic blood and urine tests to check kidney function and detect recurrence

Stage 3 or 4 cancer (locally advanced or metastatic)

• Imaging every 3–6 months for the first 2 years
• Then every 6–12 months depending on risk of recurrence
• More frequent monitoring if on immunotherapy or targeted therapy
• If only one kidney remains, kidney function tests (creatinine, eGFR) become even more important. 
• Chest imaging may be included since the lungs are a common site of metastasis.

Why Regular Monitoring Matters

• Recurrence can happen months or years after treatment
• New tumors can develop in the remaining kidney
• Metastasis might occur in distant organs like lungs, bones, or liver
• Early detection gives the best chance for successful management

Monitoring also ensures any long-term complications—such as high blood pressure or reduced kidney function—are caught and managed early.

Even if you feel well, always attend your scheduled appointments and tests. Kidney cancer can return without obvious symptoms.

Looking for more questions?

Visit our Kidney Cancer Questions page for all other topics explained in plain language.